Announced
Completed
Financials
Tags
United States
biotechnology research
Biotechnology
Private
Completed
Acquisition
Minority
Domestic
Private Equity
Friendly
Synopsis
A consortium of investors including private equity firms Adage Capital Partners, Avidity Partners, Boxer Capital, Darwin Global Management, Deep Track Capital, Farallon Capital Management, Logos Capital, Perceptive Advisors and RTW Investments, completed a $180m investment in Spyre Therapeutics, a biotechnology company. Spyre Therapeutics intends to use the net proceeds from the PIPE financing, together with the Spyre's existing cash, cash equivalents, and marketable securities, to fund its pipeline programs, and for general corporate purposes and working capital. Spyre also expects that the net proceeds will extend its cash runway to fund its operating plan well into 2027.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.